Vera Therapeutics, Inc.
VERA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $93 | $46 | $43 | $80 |
| Short-Term Investments | $548 | $115 | $71 | $0 |
| Receivables | $4 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $7 | $11 | $11 | $3 |
| Total Curr. Assets | $651 | $172 | $126 | $83 |
| Property Plant & Equip (Net) | $4 | $3 | $5 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $1 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $4 | $4 | $6 | $1 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $656 | $176 | $131 | $84 |
| Liabilities | – | – | – | – |
| Payables | $8 | $11 | $12 | $1 |
| Short-Term Debt | $1 | $2 | $3 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $16 | $9 | $11 | $6 |
| Total Curr. Liab. | $25 | $22 | $26 | $8 |
| LT Debt | $53 | $51 | $29 | $5 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $2 |
| Total NC Liab. | $53 | $52 | $29 | $6 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $4 | $4 | $6 | $0 |
| Total Liabilities | $79 | $74 | $55 | $14 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$461 | -$309 | -$213 | -$124 |
| AOCI | $0 | $0 | -$0 | $0 |
| Other Equity | $1,038 | $410 | $290 | $194 |
| Total Equity | $577 | $102 | $77 | $70 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $656 | $176 | $131 | $84 |
| Net Debt | -$38 | $8 | -$12 | -$75 |